Xgeva is a prescription medication containing denosumab, a monoclonal antibody designed to target and inhibit RANKL (Receptor Activator of Nuclear Factor Kappa-Β Ligand), a protein essential for the formation, function, and survival of osteoclasts—cells responsible for bone resorption. By binding to RANKL, Xgeva effectively reduces bone destruction associated with various conditions.
General Health & Specialty Medicines, Pharmaceutical Injections
120mg Xgeva Denosumab Injection
₹23,000.00
| Pre Filled Volume | 1.7 ml |
|---|---|
| Packaging Type | Vial |
| Manufacturer | GSK |
| Treatment | Used To Treat Osteoporosis, Bone Loss, Giant Cell Tumours Of The Bone, High Calcium Levels And Reduc |
| Pack Size | 1 Vial |
| Pack Type | Box |
| Strength | 120 mg |
| Composition | Denosumab |
Reviews
There are no reviews yet.